Literature DB >> 2758382

Obesity and breast disease. The role of the female sex hormones.

D Ingram1, E Nottage, S Ng, L Sparrow, A Roberts, D Willcox.   

Abstract

An Australian study of 513 women evaluated associations between obesity and both benign and malignant breast disease, and in particular investigated the role of female sex hormones. Women who gained more than 10 kg from early womanhood had a two-fold increase in risk of developing breast cancer, whereas lean women had a greater risk of being treated for benign breast disease. Obese women with breast cancer were more likely to have Stage II tumors but there was no significant association between obesity and tumor size or estrogen and progesterone receptor status. Obesity was strongly associated with the proportions of nonprotein-bound and albumin-bound estradiol, and inversely associated with sex hormone binding globulin (SHBG) levels and the proportion of SHBG-bound estradiol. In addition, age at menarche was inversely associated, and age at menopause directly associated with recalled weight at those time periods. These data demonstrate weight gain as a risk factor for breast cancer, and suggest a possible mechanism supporting its development.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2758382     DOI: 10.1002/1097-0142(19890901)64:5<1049::aid-cncr2820640515>3.0.co;2-m

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  10 in total

1.  Birth weight, body mass index and asthma in young adults.

Authors:  S O Shaheen; J A Sterne; S M Montgomery; H Azima
Journal:  Thorax       Date:  1999-05       Impact factor: 9.139

2.  Obesity and subcutaneous fat patterning in relation to survival of postmenopausal breast cancer patients participating in the DOM-project.

Authors:  I den Tonkelaar; F de Waard; J C Seidell; J Fracheboud
Journal:  Breast Cancer Res Treat       Date:  1995-05       Impact factor: 4.872

Review 3.  Timing of dietary fat exposure and mammary tumorigenesis: role of estrogen receptor and protein kinase C activity.

Authors:  L Hilakivi-Clarke; R Clarke
Journal:  Mol Cell Biochem       Date:  1998-11       Impact factor: 3.396

4.  The relation of body size to plasma levels of estrogens and androgens in premenopausal women (Maryland, United States).

Authors:  J F Dorgan; M E Reichman; J T Judd; C Brown; C Longcope; A Schatzkin; D Albanes; W S Campbell; C Franz; L Kahle
Journal:  Cancer Causes Control       Date:  1995-01       Impact factor: 2.506

5.  Oestrogen binding and risk factors for breast cancer.

Authors:  D M Ingram; E M Nottage; D L Willcox; A Roberts
Journal:  Br J Cancer       Date:  1990-02       Impact factor: 7.640

6.  Patient delay and stage of diagnosis among breast cancer patients in Germany -- a population based study.

Authors:  V Arndt; T Stürmer; C Stegmaier; H Ziegler; G Dhom; H Brenner
Journal:  Br J Cancer       Date:  2002-04-08       Impact factor: 7.640

7.  Established breast cancer risk factors by clinically important tumour characteristics.

Authors:  M García-Closas; L A Brinton; J Lissowska; N Chatterjee; B Peplonska; W F Anderson; N Szeszenia-Dabrowska; A Bardin-Mikolajczak; W Zatonski; A Blair; Z Kalaylioglu; G Rymkiewicz; D Mazepa-Sikora; R Kordek; S Lukaszek; M E Sherman
Journal:  Br J Cancer       Date:  2006-06-06       Impact factor: 7.640

8.  Association between Body Mass Index and Prevalence of Asthma in Korean Adults.

Authors:  Min Kang; Seok-Joon Sohn; Min-Ho Shin
Journal:  Chonnam Med J       Date:  2020-01-22

9.  The role of diet in the development of breast cancer: a case-control study of patients with breast cancer, benign epithelial hyperplasia and fibrocystic disease of the breast.

Authors:  D M Ingram; E Nottage; T Roberts
Journal:  Br J Cancer       Date:  1991-07       Impact factor: 7.640

10.  An examination of obesity and breast cancer survival in post-menopausal women.

Authors:  A Katoh; V J Watzlaf; F D'Amico
Journal:  Br J Cancer       Date:  1994-11       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.